SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

FuelCell Energy, Inc. engages in the business of developing, designing, producing, constructing, and servicing high temperature fuel cells for clean electric power generation. It operates through the following geographical segments: the United States, South Korea, and Europe. The company was founded by Bernard Baker and Martin G. Klein in 1969 and is headquartered in Danbury, CT.

Fuelcell Energy Inc

FuelCell Energy is experiencing a massive, momentum-driven rally fueled by renewed market interest in clean energy infrastructure, specifically regarding the scaling of fuel cell technology for AI-driven data centers. While some community members celebrate the price appreciation, others are voicing skepticism based on the company's long-term history of dilution and previous reverse splits, creating a sharp divide between retail bulls expecting a breakout similar to industry peers and wary bears calling for a pullback.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

Biocryst Pharmaceuticals is gaining momentum as investors eye potential M&A activity, with community discussion highlighting rumors of a buyout and the company's strategic pivot toward capital efficiency. The sentiment is fueled by heavy call option volume and signs of short covering, as the stock attempts to clear key resistance levels.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is gaining significant momentum as investors bet on the company's GLP-1 obesity pipeline, with community members actively discussing a potential breakout toward new highs. The stock is being closely monitored for a potential short squeeze as participants weigh the strength of its metabolic pipeline against the prospect of future M&A activity.

Immix Biopharma, Inc. operates as a biopharmaceutical company that engages in the development of therapies for cancer and inflammatory diseases. The company was founded by Ilya Rachman, Sean Senn, and Vladimir Torchilin in 2012 and is headquartered in Los Angeles, CA.

Immix Biopharma Inc

IMMX is generating significant momentum as institutional accumulation continues ahead of anticipated BLA filings and upcoming clinical milestones. Investors are closely tracking its Breakthrough Therapy Designation for NXC-201 and potential M&A interest within the rare disease space, driving active discussions regarding the stock's valuation upside and institutional sentiment.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

Navitas Semiconductor is facing significant volatility and market pressure due to a patent infringement lawsuit from Wolfspeed and broader sector rotation away from high-beta AI infrastructure plays. While community sentiment remains polarized, many investors are focused on the company's long-term potential in GaN and SiC power technology as they look for stabilization near key technical support levels.

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. It will generate domestically produced bitcoin powered by nuclear, hydro, and solar energy. It operates through the Digital Asset Mining and HPC Leasing segments. The company was founded by Paul B. Prager and Nazar M. Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

TeraWulf is trending following a massive 20-year, $19 billion lease agreement with Anthropic for AI data center capacity, a catalyst that has sparked intense debate over the stock's valuation and the company's transformation into an AI infrastructure powerhouse. Community members are actively discussing whether the price action reflects legitimate market manipulation by short sellers or a typical 'sell the news' reaction, while others argue the deal validates the company's long-term potential as a critical player in the energy-intensive AI sector.

Penguin Solutions, Inc. engages in designing, building, and managing enterprise solutions. It operates through the following segments: Advanced Computing, Integrated Memory, and Optimized LED. The Advanced Computing segment offers platform solutions and services for artificial intelligence, high-performance computing, machine learning, advanced modeling, and the internet of things. The Integrated Memory refers to integrated memory solutions through the design and development. The Optimized LED segment comprises a broad portfolio of application-optimized LEDs. The company was founded in 1988 and is headquartered in Fremont, CA.

Penguin Solutions Inc.

Penguin Solutions is trending as investors react to a strong quarterly earnings report that highlighted record revenue growth driven by significant demand for AI infrastructure and integrated memory solutions. The community is actively debating the company's long-term sustainability due to its heavy reliance on AI spending, upcoming share dilution, and concerns about potential margin compression as memory market conditions evolve.

Delta Air Lines, Inc. engages in the provision of scheduled air transportation for passengers and cargo. It operates through the Airline and Refinery segments. The Airline segment provides scheduled air transportation for passengers and cargo. The Refinery segment provides jet fuel to the airline segment. The company was founded by Collett Everman Woolman in 1928 and is headquartered in Atlanta, GA.

Delta Air Lines, Inc.

Delta Air Lines is at the center of investor focus as the carrier navigates a turbulent environment marked by volatile jet fuel costs and ongoing geopolitical pressures in the Middle East. The community is actively debating the stock's resilience, weighing strong premium travel demand and recent institutional activity against significant margin headwinds and operational concerns.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius is gaining momentum as investors rotate back into consumer growth stories, with the market actively debating the stock's significant short interest and its potential as a long-term challenger to dominant players in the energy drink sector. Community sentiment remains polarized between aggressive bulls highlighting international expansion and strong brand loyalty, and skeptics who are closely monitoring valuation concerns and competitive pressures.

Arbutus Biopharma Corp. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics that target specific viral diseases. It focuses on the development of imdusiran (AB-729), proprietary, conjugated GalNAc, subcutaneously-delivered RNAi therapeutic, and AB-101, proprietary oral PD-L1 inhibitor, for the treatment of chronic hepatitis B (cHBV). The company was founded on October 6, 2005 and is headquartered in Warminster, PA.

Arbutus Biopharma Corp

Arbutus Biopharma is trending as investors focus on imminent payouts from a global settlement with Moderna and the potential for a substantial, high-value settlement with Pfizer. The community is actively debating the stock's significant undervaluation, the potential for a strategic buyout, and the impact of the FDA Fast Track designation for Imdusiran on the companys long-term clinical valuation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
